Clinical Trial Update: A Phase 2 Study Evaluating the Safety and Efficacy of Netarsudil Ophthalmic Solution in Patients With Corneal Edema Due to Fuchs Corneal Dystrophy [Phase 2]

View source ↗

Summary

Phase 2 study evaluating safety and efficacy of Netarsudil ophthalmic solution for corneal edema due to Fuchs corneal dystrophy has completed with posted result…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Corneal Edema
• Fuchs Endothelial Corneal Dystrophy

Drugs mentioned

• netarsudil ophthalmic solution (netarsudil)

Snippet

Sponsor: Aerie Pharmaceuticals | Conditions: Corneal Edema | Phase 2 | Status: COMPLETED | Results posted: 2022-09-01